Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Fulgent Genetics stock

Learn how to easily invest in Fulgent Genetics stock.

Fulgent Genetics is a diagnostics & research business based in the US. Fulgent Genetics shares (FLGT) are listed on the NASDAQ and all prices are listed in US Dollars. Fulgent Genetics employs 645 staff and has a trailing 12-month revenue of around $802.9 million.

How to buy Fulgent Genetics stock

  1. Open a stock trading account. Use our comparison table or choose from our Top Picks.
  2. Confirm your payment details. Fund your account with a bank transfer, debit card or credit card and take advantage of any signup bonuses.
  3. Search for the stock by name or ticker symbol – FLGT. It's that simple.

Best for low fees

Finder Award

SoFi Invest


  • Trade stocks for $0 and no annual fee
  • Start trading with a $0 minimum deposit
  • Get up to $1,000 when you fund a new account within 30 days

Promoted for easy user experience

Robinhood


  • Commission-free trading
  • Commission-free crypto
  • No minimum account balance

Promoted

tastyworks


  • $0 commissions on stocks and ETFs
  • $0 closing commissions on stock and ETF options
  • Get $200 in US stocks when you open and fund an account with min. $2,000 for 3+ mos.

Fulgent Genetics stock price (NASDAQ: FLGT)

Use our graph to track the performance of FLGT stocks over time.

Fulgent Genetics shares at a glance

Information last updated 2023-01-24.
Latest market close$33.03
52-week range$28.53 - $73.47
50-day moving average $33.45
200-day moving average $45.62
Wall St. target price$45.00
PE ratio 3.901
Dividend yield $0 (0%)
Earnings per share (TTM) $8.59

Buy Fulgent Genetics stocks from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 5 of 5
Name Product Available asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, Options, ETFs, Cryptocurrency
$0
$0
Get up to $1,000
when you fund a new account within 30 days.
Winner of Finder’s Best Low-Cost Broker award.
Robinhood
Stocks, Options, ETFs, Cryptocurrency
$0
$0
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 4% interest on uninvested cash in your account with Robinhood Gold.
tastyworks
Stocks, Options, ETFs, Cryptocurrency
$0
$0
Get $200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Highly commended for Best Derivatives Trading Platform award.
Public.com
Stocks, ETFs, Cryptocurrency, Alternatives
$0
$0
Get up to $300 in either stocks or crypto
when you use code FINDERUS to sign up and fund a new account.
Trade stocks and ETFs commission-free, plus gain access to alternative investments like art, NFTs and more.
Interactive Brokers
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency, Futures, Forex
$0
$0
N/A
Winner of Finder’s Best Overall Stock Broker award.
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.

Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.

Is it a good time to buy Fulgent Genetics stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Fulgent Genetics price performance over time

Historical closes compared with the close of $33.03 from 2023-01-25

1 week (2023-01-19) 3.70%
1 month (2022-12-23) 8.94%
3 months (2022-10-25) -13.53%
6 months (2022-07-26) -42.76%
1 year (2022-01-26) -46.72%
2 years (2021-01-26) -56.32%
3 years (2020-01-24) 154.86%
5 years (2018-01-26) 537.64%

Is Fulgent Genetics stock undervalued or overvalued?

Valuing Fulgent Genetics stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Fulgent Genetics's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Fulgent Genetics's P/E ratio

Fulgent Genetics's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 4x. In other words, Fulgent Genetics shares trade at around 4x recent earnings.

That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.

Fulgent Genetics's PEG ratio

Fulgent Genetics's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.32. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Fulgent Genetics's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

Fulgent Genetics's EBITDA

Fulgent Genetics's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $401.1 million.

The EBITDA is a measure of a Fulgent Genetics's overall financial performance and is widely used to measure a its profitability.

Fulgent Genetics financials

Revenue TTM $802.9 million
Operating margin TTM 46.7%
Gross profit TTM $777.1 million
Return on assets TTM 17.95%
Return on equity TTM 23.19%
Profit margin 33.82%
Book value $43.03
Market capitalisation $1 billion

TTM: trailing 12 months

Fulgent Genetics share dividends

We're not expecting Fulgent Genetics to pay a dividend over the next 12 months.

Fulgent Genetics share price volatility

Over the last 12 months, Fulgent Genetics's shares have ranged in value from as little as $28.53 up to $73.47. A popular way to gauge a stock's volatility is its "beta".

FLGT.US volatility(beta: 1.58)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Fulgent Genetics's is 1.5842. This would suggest that Fulgent Genetics's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Fulgent Genetics overview

Fulgent Genetics, Inc. , together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions; solid tumor molecular profiling for somatic cancer testing; rapid whole genome testing for children in NICU and PICU; newborn genetic analysis panel; single front-line test to detect ataxia-related variants and repeat expansions through sequencing; picture genetics, a patient-initiated genetic testing; whole exome and clinical exome panel tests; whole genome, mutation, and repeat expansion testing services, as well as research service tests. It also provides next generation sequencing and reverse transcription polymerase chain reaction-based tests, as well as antigen-based diagnostic tests for the detection of SARS-CoV-2. In addition, the company offers flow cytometry, a cell analysis technique providing diagnosis, prognosis, and monitoring of malignancies; fluorescence in-situ hybridization for detecting and locating a specific DNA sequence on a chromosome; immunohistochemistry, an imaging technique used to visualize antigens in cells; cytogenetics, which analyzes the chromosome set for numerical and structural abnormalities; and molecular testing that includes hematopoietic and solid tumor molecular assays. The company serves insurance, hospitals, medical institutions, other laboratories, governmental bodies, payors, municipalities and large corporations, and patients. Fulgent Genetics has strategic partnership with Helio Health, Inc.

Frequently asked questions

What percentage of Fulgent Genetics is owned by insiders or institutions?
Currently 33.803% of Fulgent Genetics shares are held by insiders and 46.473% by institutions.
How many people work for Fulgent Genetics?
Latest data suggests 645 work at Fulgent Genetics.
When does the fiscal year end for Fulgent Genetics?
Fulgent Genetics's fiscal year ends in December.
Where is Fulgent Genetics based?
Fulgent Genetics's address is: 4978 Santa Anita Avenue, Temple City, CA, United States, 91780
What is Fulgent Genetics's ISIN number?
Fulgent Genetics's international securities identification number is: US3596641098
What is Fulgent Genetics's CUSIP number?
Fulgent Genetics's Committee on Uniform Securities Identification Procedures number is: 359664109

More guides on Finder

Ask an Expert

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site